Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan

Table 6 Classification and economic impact of pharmaceutical interventions

Intervention type	Number of cases of avoided ADRs	Cost savings per case (USD)	Cost savings (USD)
Avoidance of serious adverse drug reactions (ADRs)	56	21,400	1,198,400
Transvenous antimicrobial therapy interventions^a	265	1900	503,500
Interventions concerning cancer chemotherapy	210	1120	235,200
Avoidance of drug interactions
High-risk drugs	8	840	6720
Normal drugs	20	560	11,200
Renal dosing recommendations
High-risk drugs	89	840	74,760
Normal drugs	296	560	165,760
Avoiding intravenous drug incompatibility
High-risk drugs	0	840	0
Normal drugs	0	560	0
Confirmation of medication history
High-risk drugs	21	840	17,640
Normal drugs	39	560	21,840
Drug therapy consultation/recommendation (non-renal/extensive)
High-risk drugs	160	840	134,400
Normal drugs	515	560	288,400
Monitoring recommendation	80	0	0
Prescription term adjustment until next consultation day	0	0	0
Overall	1759		2,657,820

ISSN: 2055-0294